Gate Bioscience
Athena Chen is a Data Scientist & Statistician II at Gate Bioscience, having progressed from Data Scientist & Statistician I since April 2022. Prior experience includes serving as a Graduate Research Assistant at Johns Hopkins Bloomberg School of Public Health from December 2017 to April 2022, where significant work involved developing a classifier for distinguishing between recent and non-recent HIV infections. Athena also contributed as a Graduate Teaching Assistant for various advanced data science and statistical methods courses and was previously a Research Assistant at The Johns Hopkins University from December 2015 to August 2017. Athena holds a PhD in Biostatistics from Johns Hopkins Bloomberg School of Public Health and a BA in Biophysics and Applied Mathematics and Statistics from The Johns Hopkins University. Relevant early experience includes internships in project management and marketing.
This person is not in any offices
Gate Bioscience
Gate Bioscience is a preclinical biotechnology company creating a new class of medicines called Molecular Gates. Molecular Gates are small molecule drugs that selectively eliminate harmful extracellular proteins at their origin: inside the cell. Humans produce over 4,000 distinct extracellular proteins, more than 1,000 of which can drive disease when they act improperly, misfold, or are made at the wrong time, in the wrong place, or at incorrect levels. By eliminating these disease-causing proteins, we aim to eliminate diseases for patients. Molecular Gates act by a completely new therapeutic mechanism. All extracellular proteins pass through single channel in the cell as they are secreted into the body. Molecular Gates bind to this channel, setting up a “gate” that recognizes and blocks a specific, disease-causing protein from exiting. With nowhere to go, the harmful protein is degraded by the cell instead of being secreted. Our mission to create Molecular Gate medicines is backed by Versant Ventures, a16z Bio + Health, ARCH Venture Partners, and GV. Learn more at www.gatebio.com.